{
    "clinical_study": {
        "@rank": "164674", 
        "arm_group": [
            {
                "arm_group_label": "Deep neuromuscular blockade", 
                "arm_group_type": "Active Comparator", 
                "description": "Drug: Rocuronium Intravenous use: 0.3 mg/kg before intubation and 0,7 mg after intubation followed by infusion with 0,3-0,4 mg/kg/h Other Name: Esmeron"
            }, 
            {
                "arm_group_label": "Moderate neuromuscular blockade", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Drug: Rocuronium Intravenous use: 0,3 mg/kg followed by NaCl-infusion Other Name: Esmeron"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study on laparoscopic hysterectomy is to investigate postoperative pain.\n      Patients are allocated to either deep neuromuscular blockade and low intra-abdominal\n      pressure (8 mmHg) or moderate neuromuscular blockade and usual intra-abdominal pressure (12\n      mmHg).\n\n      Primary hypothesis:\n\n      Deep neuromuscular blockade and low intra-abdominal pressure (8 mmHg) reduces postoperative\n      pain compared to moderate neuromuscular blockade and intra-abdominal pressure (12 mmHg)."
        }, 
        "brief_title": "Recovery After Laparoscopic Hysterectomy With Deep Neuromuscular Blockade and Low Intra-abdominal Pressure", 
        "completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Neuromuscular Blockade", 
            "Pain", 
            "Laparoscopy"
        ], 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Elective laparoscopic hysterectomy (total/subtotal)\n\n          -  Can read and understand Danish\n\n          -  Informed consent\n\n        Exclusion Criteria:\n\n          -  BMI > 30 kg/cm2\n\n          -  Known allergy to medications that are included in the project\n\n          -  Severe renal disease, defined by S-creatinine > 0,200 mmol/L, GFR < 30ml/min or\n             hemodialysis)\n\n          -  Neuromuscular disease that may interfere with neuromuscular data\n\n          -  Lactating\n\n          -  Impaired liver function\n\n          -  Indication for rapid sequence induction (esophageal reflux/ hiatus hernia/other\n             cause)"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "98", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 2, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01722097", 
            "org_study_id": "NMBDK2012", 
            "secondary_id": "2012-003787-51"
        }, 
        "intervention": [
            {
                "arm_group_label": "Deep neuromuscular blockade", 
                "intervention_name": "Rocuronium", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Moderate neuromuscular blockade", 
                "intervention_name": "placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Rocuronium"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 10, 2014", 
        "location": {
            "contact": {
                "email": "olav.istre@aleris-hamlet.dk", 
                "last_name": "Olav Istre, MD, DMSc, professor", 
                "phone": "+45 21277472"
            }, 
            "facility": {
                "address": {
                    "city": "S\u00f8borg", 
                    "country": "Denmark", 
                    "zip": "2830"
                }, 
                "name": "Department of anesthesia and department of minimal invasive gynecology, Aleris-Hamlet"
            }, 
            "investigator": {
                "last_name": "Matias Vested Madsen, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Denmark"
        }, 
        "number_of_arms": "2", 
        "official_title": "Recovery After Laparoscopic Hysterectomy With Deep Neuromuscular Blockade and Low Intra-abdominal Pressure", 
        "other_outcome": {
            "description": "Number of unintended and unwanted patient-movements registered by the surgeon", 
            "measure": "Patient-movements", 
            "safety_issue": "Yes", 
            "time_frame": "During surgery"
        }, 
        "overall_contact": {
            "email": "matias.vested.madsen@regionh.dk", 
            "last_name": "Matias Vested Madsen, MD", 
            "phone": "+4538689058"
        }, 
        "overall_contact_backup": {
            "email": "mona.gatke@regionh.dk", 
            "last_name": "Mona G\u00e4tke, MD, ph.d", 
            "phone": "+4538682420"
        }, 
        "overall_official": [
            {
                "affiliation": "Department of anesthesia, Herlev Hospital", 
                "last_name": "Mona G\u00e4tke, MD, ph.d.", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Department of anesthesia, Herlev Hospital", 
                "last_name": "Matias Vested Maden, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Denmark: Danish Health and Medicines Authority", 
                "Denmark: The National Committee on Health Research Ethics"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Occurrence of shoulder pain (evaluated on a VAS scale) or discomfort in the shoulder region within 14 days after operation", 
            "measure": "Shoulder pain", 
            "safety_issue": "No", 
            "time_frame": "within 14 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01722097"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Herlev Hospital", 
            "investigator_full_name": "Matias Vested Madsen", 
            "investigator_title": "research assistent, MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Pain (shoulder-, incisional-, abdominal - and overall pain) estimated as area under the curve from preoperatively till 4 days after operation Pain (shoulder-, incisional-, abdominal - and overall pain) estimated as area under the curve from preoperatively till 14 days after operation", 
            "measure": "Pain", 
            "safety_issue": "No", 
            "time_frame": "within 4 days"
        }, 
        "source": "Herlev Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Herlev Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}